The institute seminar on Wednesday February 13th will be held by Jostein Dahle, head of the Radiotherapy project group at the Department of Radiation Biology.
The title of his talk is "Alpha‐particle based radioimmunotherapy of cancer"
Time and place: 12:00, Seminar Room, F4, Institute for Cancer Research.
From major journals, first or last author from the Institute for Cancer Research
Trachsel-Moncho L, Mathai BJ, Veroni C, Simonsen A(2025) SNX10 at the crossroad of endocytosis and piecemeal mitophagy Autophagy, 1-3(in press) DOI 10.1080/15548627.2025.2499641, PubMed 40327657
Hektoen HH, Tsuruda KM, Brustugun OT, Neumann K, Andreassen BK(2025) Real-world comparison of pembrolizumab alone and combined with chemotherapy in metastatic lung adenocarcinoma patients with PD-L1 expression ≥50 ESMO Open, 10(5), 105073(in press) DOI 10.1016/j.esmoop.2025.105073, PubMed 40305908
Dillard C, Teles-Reis J, Jain A, Antunes MG, Ruiz-Duran P, Qi Y, Le Borgne R, Jasper H, Rusten TE(2025) NF-κB signaling driven by oncogenic Ras contributes to tumorigenesis in a Drosophila carcinoma model PLoS Biol, 23(4), e3002663 DOI 10.1371/journal.pbio.3002663, PubMed 40294135
Garcia-Foncillas J, Bayle A, Arnold D, Avouac B, Awada A, de la Cruz-Merino L, Helland Å, Lassen U, Laurent-Puig P, Normanno N, Rohrberg K, Taieb J, Stenzinger A(2025) Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access Future Oncol, 1-8(in press) DOI 10.1080/14796694.2025.2501523, PubMed 40340714
Trachsel-Moncho L, Mathai BJ, Veroni C, Simonsen A(2025) SNX10 at the crossroad of endocytosis and piecemeal mitophagy Autophagy, 1-3(in press) DOI 10.1080/15548627.2025.2499641, PubMed 40327657
Rosenberger L, Hansmann L, Anastasopoulou V, Wolf SP, Drousch K, Moewes C, Feng X, Cao G, Huang J, Yew PY, Strønen E, Kato T, Saligrama N, Olweus J, Nakamura Y, Willimsky G, Blankenstein T, Schreiber H, Leisegang M(2025) Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire J Immunother Cancer, 13(5) DOI 10.1136/jitc-2024-011351, PubMed 40316304